Stocktoria

Praxis Precision Medicines, Inc. PRAX

Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-10-16
Chart by TradingView
2/9
Piotroski F — financial health
12.98
Altman Z″ — distress risk · safe
Dividend payout · no dividend

Valuation · market cap as of 2026-06-29

Market cap$9.1B
P / B10.4×

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022FY2021
Financials
Revenue$0$8.6M$2.4M$0
Operating income-$326.2M-$200.2M-$126.4M-$215.0M-$167.3M
Net income-$303.3M-$182.8M-$123.3M-$214.0M-$167.1M
Operating cash flow-$249.1M-$131.8M-$111.1M-$185.0M-$124.6M
Free cash flow-$249.1M-$131.8M-$111.2M-$185.5M-$125.6M
Total assets$937.9M$483.1M$87.9M$115.1M$292.7M
Total liabilities$59.8M$37.7M$18.3M$39.0M$41.9M
Shareholders' equity$878.1M$445.4M$69.7M$76.1M$250.8M
Ratios
Operating margin-2340.3%-5164.4%
Net margin-2137.5%-5037.9%
FCF margin-1540.5%-4543.8%
Return on assets-32.3%-37.8%-140.2%-185.9%-57.1%
Return on equity-34.5%-41.0%-176.9%-281.2%-66.6%
Current ratio10.2210.775.393.237.48
Revenue growth-100.0%249.5%

Why these scores methodology →

Piotroski F-score: 2/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: 12.98 (safe)

  • Working capital / assets 0.588
  • Retained earnings / assets -1.215
  • EBIT / assets -0.348
  • Equity / liabilities 14.692

Sector peers

VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →

Source: SEC EDGAR filings · CIK 0001689548 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.